Alyeska Investment Group, L.P.

Position in OBIO — Orchestra BioMed Holdings, Inc.

CIK 1453072 CHICAGO, IL

Position in OBIO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,315,000

+$65,000 QoQ

Shares Held

1,000,000

0.0% QoQ

Ownership

1.66%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

of 77 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $989,063,778 across 83 Biotechnology names. OBIO ranks #47 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	659,279	$123,469,771
2	IONS	Ionis Pharmaceuticals Inc	1,417,916	$112,426,559
3	PTGX	Protagonist Therapeutics, Inc	889,298	$109,010,148
4	XENE	Xenon Pharmaceuticals Inc.	697,692	$42,112,689
5	MRNA	Moderna, Inc.	560,819	$39,274,154
6	KYMR	Kymera Therapeutics, Inc.	276,455	$31,701,094
7	LBRX	Lb Pharmaceuticals Inc	863,947	$28,039,399
8	PRAX	Praxis Precision Medicines, Inc.	80,846	$27,066,432

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,315,000	1,000,000	0.0%	Shares	Sole	2026-08-14
2026-03-31	$4,250,000	1,000,000	0.0%	Shares	Sole	2026-05-15
2025-12-31	$4,150,000	1,000,000	-26.8%	Shares	Sole	2026-02-13
2025-09-30	$3,386,395	1,365,482	—	Shares	Sole	2025-11-17
2022-06-30 HSAQ	—	25,000	0.0%	Shares	Sole	2022-08-15
2022-03-31 HSAQ	—	25,000	0.0%	Shares	Sole	2022-05-17
2021-12-31 HSAQ	—	25,000	0.0%	Shares	Sole	2022-02-14
2021-09-30 HSAQ	—	25,000	0.0%	Shares	Sole	2021-11-15
2021-06-30 HSAQ	—	25,000	0.0%	Shares	Sole	2021-08-16
2021-03-31 HSAQ	—	25,000	0.0%	Shares	Sole	2021-05-17
2020-12-31 HSAQ	—	25,000	-0.8%	Shares	Sole	2021-02-16
2020-09-30 HSAQ	—	25,200	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.